Gastrointestinal pathology in sickle cell disease

Jonathan S. Krauss, Lawrence J. Freant, Jeffrey R Lee

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The literature was reviewed to investigate the existence of unique gastrointestinal (GI) pathological lesions in sickle-cell disease (SCD). Chole- and choledocholithiasis have long been recognized, but bilirubin gallstones can occur in any chronic hemolyric anemia. Acute pancreatitis has been reported as a possible ischemic consequence of sickling. It is unclear if the hepatic lesions of SCD differ from those of any chronically transfused population. Hepatic failure has been associated with massive sickling and hyperviscous bile ('sludge') has been linked to SCD. Elevated 5'-nucleotidase in the presence of elevated aminotransferase may suggest both hepatic and biliary tree involvement in a subgroup of patients with SCD. Low levels of the hepatically produced coagulation inhibitors, Protein S and Protein C, have been identified in SCD, but their precise relation to thrombosis in this instance remains unclear. Finally, a syndrome of intracanalicular cholestasis, sinusoidal dilation, Kupffer cell hyperplasia, and erythrophagocytosis has been linked to SCD. It has been suggested that the use of exchange transfusion prior to liver biopsy in this group of pediatric SCD patients may mask the pathophysiological role of sickled red blood cells in hepatic dysfunction. With the exception of some of the situations cited, it is concluded that most GI lesions in SCD are common to a heavily transfused population with chronic hemolytic anemia.

Original languageEnglish (US)
Pages (from-to)19-23
Number of pages5
JournalAnnals of Clinical and Laboratory Science
Volume28
Issue number1
StatePublished - Mar 12 1998

Fingerprint

Sickle Cell Anemia
Pathology
Liver
Choledocholithiasis
5'-Nucleotidase
Pediatrics
Kupffer Cells
Biopsy
Hemolytic Anemia
Protein S
Cholestasis
Liver Failure
Biliary Tract
Gallstones
Masks
Sewage
Transaminases
Protein C
Coagulation
Bilirubin

ASJC Scopus subject areas

  • Microbiology
  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology
  • Molecular Biology
  • Hematology
  • Clinical Biochemistry
  • Medical Laboratory Technology

Cite this

Krauss, J. S., Freant, L. J., & Lee, J. R. (1998). Gastrointestinal pathology in sickle cell disease. Annals of Clinical and Laboratory Science, 28(1), 19-23.

Gastrointestinal pathology in sickle cell disease. / Krauss, Jonathan S.; Freant, Lawrence J.; Lee, Jeffrey R.

In: Annals of Clinical and Laboratory Science, Vol. 28, No. 1, 12.03.1998, p. 19-23.

Research output: Contribution to journalArticle

Krauss, JS, Freant, LJ & Lee, JR 1998, 'Gastrointestinal pathology in sickle cell disease', Annals of Clinical and Laboratory Science, vol. 28, no. 1, pp. 19-23.
Krauss, Jonathan S. ; Freant, Lawrence J. ; Lee, Jeffrey R. / Gastrointestinal pathology in sickle cell disease. In: Annals of Clinical and Laboratory Science. 1998 ; Vol. 28, No. 1. pp. 19-23.
@article{592cb5e81d1a46c9a537cbada01b80cf,
title = "Gastrointestinal pathology in sickle cell disease",
abstract = "The literature was reviewed to investigate the existence of unique gastrointestinal (GI) pathological lesions in sickle-cell disease (SCD). Chole- and choledocholithiasis have long been recognized, but bilirubin gallstones can occur in any chronic hemolyric anemia. Acute pancreatitis has been reported as a possible ischemic consequence of sickling. It is unclear if the hepatic lesions of SCD differ from those of any chronically transfused population. Hepatic failure has been associated with massive sickling and hyperviscous bile ('sludge') has been linked to SCD. Elevated 5'-nucleotidase in the presence of elevated aminotransferase may suggest both hepatic and biliary tree involvement in a subgroup of patients with SCD. Low levels of the hepatically produced coagulation inhibitors, Protein S and Protein C, have been identified in SCD, but their precise relation to thrombosis in this instance remains unclear. Finally, a syndrome of intracanalicular cholestasis, sinusoidal dilation, Kupffer cell hyperplasia, and erythrophagocytosis has been linked to SCD. It has been suggested that the use of exchange transfusion prior to liver biopsy in this group of pediatric SCD patients may mask the pathophysiological role of sickled red blood cells in hepatic dysfunction. With the exception of some of the situations cited, it is concluded that most GI lesions in SCD are common to a heavily transfused population with chronic hemolytic anemia.",
author = "Krauss, {Jonathan S.} and Freant, {Lawrence J.} and Lee, {Jeffrey R}",
year = "1998",
month = "3",
day = "12",
language = "English (US)",
volume = "28",
pages = "19--23",
journal = "Annals of Clinical and Laboratory Science",
issn = "0091-7370",
publisher = "Association of Clinical Scientists",
number = "1",

}

TY - JOUR

T1 - Gastrointestinal pathology in sickle cell disease

AU - Krauss, Jonathan S.

AU - Freant, Lawrence J.

AU - Lee, Jeffrey R

PY - 1998/3/12

Y1 - 1998/3/12

N2 - The literature was reviewed to investigate the existence of unique gastrointestinal (GI) pathological lesions in sickle-cell disease (SCD). Chole- and choledocholithiasis have long been recognized, but bilirubin gallstones can occur in any chronic hemolyric anemia. Acute pancreatitis has been reported as a possible ischemic consequence of sickling. It is unclear if the hepatic lesions of SCD differ from those of any chronically transfused population. Hepatic failure has been associated with massive sickling and hyperviscous bile ('sludge') has been linked to SCD. Elevated 5'-nucleotidase in the presence of elevated aminotransferase may suggest both hepatic and biliary tree involvement in a subgroup of patients with SCD. Low levels of the hepatically produced coagulation inhibitors, Protein S and Protein C, have been identified in SCD, but their precise relation to thrombosis in this instance remains unclear. Finally, a syndrome of intracanalicular cholestasis, sinusoidal dilation, Kupffer cell hyperplasia, and erythrophagocytosis has been linked to SCD. It has been suggested that the use of exchange transfusion prior to liver biopsy in this group of pediatric SCD patients may mask the pathophysiological role of sickled red blood cells in hepatic dysfunction. With the exception of some of the situations cited, it is concluded that most GI lesions in SCD are common to a heavily transfused population with chronic hemolytic anemia.

AB - The literature was reviewed to investigate the existence of unique gastrointestinal (GI) pathological lesions in sickle-cell disease (SCD). Chole- and choledocholithiasis have long been recognized, but bilirubin gallstones can occur in any chronic hemolyric anemia. Acute pancreatitis has been reported as a possible ischemic consequence of sickling. It is unclear if the hepatic lesions of SCD differ from those of any chronically transfused population. Hepatic failure has been associated with massive sickling and hyperviscous bile ('sludge') has been linked to SCD. Elevated 5'-nucleotidase in the presence of elevated aminotransferase may suggest both hepatic and biliary tree involvement in a subgroup of patients with SCD. Low levels of the hepatically produced coagulation inhibitors, Protein S and Protein C, have been identified in SCD, but their precise relation to thrombosis in this instance remains unclear. Finally, a syndrome of intracanalicular cholestasis, sinusoidal dilation, Kupffer cell hyperplasia, and erythrophagocytosis has been linked to SCD. It has been suggested that the use of exchange transfusion prior to liver biopsy in this group of pediatric SCD patients may mask the pathophysiological role of sickled red blood cells in hepatic dysfunction. With the exception of some of the situations cited, it is concluded that most GI lesions in SCD are common to a heavily transfused population with chronic hemolytic anemia.

UR - http://www.scopus.com/inward/record.url?scp=0031914797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031914797&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 19

EP - 23

JO - Annals of Clinical and Laboratory Science

JF - Annals of Clinical and Laboratory Science

SN - 0091-7370

IS - 1

ER -